Analyst rating accuracy & track record
Jeffrey Hung is an equity research analyst at Morgan Stanley. Bullish Whales has scored 25 of their stock calls across 16 companies. Their picks beat their sector 62% of the time over the next 12 months, and their price targets were reached 55% of the time within a year.
Track record
Bullish Whales has scored 25 of Jeffrey Hung's stock calls across 16 companies, dating back to 2021. Their rated stocks beat their own sector 62% of the time over the next 12 months. On a typical call, a Hung pick returned +10.4% more than its sector over the following year.
Of the scored calls, 17 were bullish (Buy) and 8 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.
Coverage & ratings
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 CGONCG Oncology, Inc. Common stock | Buy | $52.00 | May 2025 | +127.0% | Hit |
 CTNMContineum Therapeutics, Inc. Class A Common Stock | Buy | $20.00 | May 2025 | +221.8% | Miss |
 RAREUltragenyx | Buy | $65.00 | May 2025 | −34.2% | Miss |
 ENGNenGene Holdings Inc. Common Stock | Buy | $34.00 | Mar 2025 | +22.5% | Miss |
 IRONDisc Medicine Inc. | Buy | $85.00 | Mar 2025 | +14.0% | Hit |
 CNTACentessa Pharmaceuticals PLC ADR | Buy | $27.00 | Mar 2025 | +58.8% | Hit |
 CGEMCullinan Oncology LLC | Buy | $35.00 | Mar 2025 | +81.6% | Miss |
| CTNMContineum Therapeutics, Inc. Class A Common Stock | Buy | $25.00 | Mar 2025 | +76.7% | Miss |
 BIOABioAge Labs, Inc | Sell | $5.00 | Mar 2025 | −349.4% | Hit |
 RYTMRhythm Pharmaceuticals Inc | Buy | $72.00 | Mar 2025 | +85.2% | Hit |
 NBIXNeurocrine Biosciences Inc | Buy | $150.00 | Mar 2025 | +10.9% | Hit |
| CGONCG Oncology, Inc. Common stock | Buy | $55.00 | Mar 2025 | +127.7% | Hit |
 PTCTPTC Therapeutics Inc | Buy | $70.00 | Mar 2025 | +24.0% | Hit |
 JAZZJazz Pharmaceuticals PLC | Buy | $183.00 | Mar 2025 | +28.6% | Hit |
| BIOABioAge Labs, Inc | Buy | $40.00 | Oct 2024 | −75.4% | Miss |
| CNTACentessa Pharmaceuticals PLC ADR | Buy | $26.00 | Sep 2024 | +47.5% | Miss |
| ENGNenGene Holdings Inc. Common Stock | Buy | $40.00 | Sep 2024 | −0.1% | Miss |
| CTNMContineum Therapeutics, Inc. Class A Common Stock | Buy | $25.00 | Apr 2024 | −74.9% | Miss |
 PRLDPrelude Therapeutics Inc | Sell | $4.00 | Dec 2023 | +81.8% | Hit |
 CELUCelularity Inc | Sell | $1.00 | Jan 2023 | +66.8% | Hit |
 EVFMEvofem Biosciences Inc | Sell | $0.75 | Jul 2022 | +119.4% | Hit |
| EVFMEvofem Biosciences Inc | Sell | $2.00 | May 2022 | +105.6% | Hit |
| EVFMEvofem Biosciences Inc | Sell | $0.57 | Apr 2022 | +93.0% | Hit |
| EVFMEvofem Biosciences Inc | Sell | $0.53 | Mar 2022 | +97.5% | Hit |
 APREAprea Therapeutics Inc | Sell | $3.00 | Aug 2021 | +74.9% | Hit |
Jeffrey Hung: analyst track record FAQ
Is Jeffrey Hung a good stock analyst?
Yes, by track record. Jeffrey Hung ranks number 11 of 347 of the analysts Bullish Whales scores, with a BW Score of 81 out of 100. Their edge holds up after we account for testing thousands of analysts at once, so they clear our Skilled bar. Past results do not guarantee future ones.
What is Jeffrey Hung's win rate?
Jeffrey Hung's win rate is 62%. Across 25 scored calls, their rated stocks beat their sector 62% of the time over the next 12 months. On a typical call they returned +10.4% more than the sector.
What stocks and sectors does Jeffrey Hung cover?
Jeffrey Hung covers 16 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.
Are Jeffrey Hung's price targets accurate?
Jeffrey Hung's price targets are reached within 12 months 55% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.
How accurate are Wall Street analyst price targets?
Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.
Should I follow Jeffrey Hung's stock ratings?
Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.
How does Bullish Whales score analyst accuracy?
Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.
How does Jeffrey Hung rank among Wall Street analysts?
Jeffrey Hung ranks number 11 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.